Literature DB >> 23151158

Norovirus vaccine development: next steps.

Robert L Atmar, Mary K Estes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23151158      PMCID： PMC3757541          DOI： 10.1586/erv.12.78

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  20 in total

Review 1.  Norwalk virus vaccines: challenges and progress.

Authors:  M K Estes; J M Ball; R A Guerrero; A R Opekun; M A Gilger; S S Pacheco; D Y Graham
Journal:  J Infect Dis       Date:  2000-05       Impact factor: 5.226

2.  Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers.

Authors:  R G Wyatt; R Dolin; N R Blacklow; H L DuPont; R F Buscho; T S Thornhill; A Z Kapikian; R M Chanock
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

3.  Recombinant Norwalk virus-like particles given orally to volunteers: phase I study.

Authors:  J M Ball; D Y Graham; A R Opekun; M A Gilger; R A Guerrero; M K Estes
Journal:  Gastroenterology       Date:  1999-07       Impact factor: 22.682

4.  Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults.

Authors:  P C Johnson; J J Mathewson; H L DuPont; H B Greenberg
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

5.  Heterotypic humoral and cellular immune responses following Norwalk virus infection.

Authors:  Lisa C Lindesmith; Eric Donaldson; Juan Leon; Christine L Moe; Jeffrey A Frelinger; Robert E Johnston; David J Weber; Ralph S Baric
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

Review 6.  Norovirus gastroenteritis.

Authors:  Roger I Glass; Umesh D Parashar; Mary K Estes
Journal:  N Engl J Med       Date:  2009-10-29       Impact factor: 91.245

7.  Clinical immunity in acute gastroenteritis caused by Norwalk agent.

Authors:  T A Parrino; D S Schreiber; J S Trier; A Z Kapikian; N R Blacklow
Journal:  N Engl J Med       Date:  1977-07-14       Impact factor: 91.245

8.  Cross-reactivity among several recombinant calicivirus virus-like particles (VLPs) with monoclonal antibodies obtained from mice immunized orally with one type of VLP.

Authors:  Noritoshi Kitamoto; Tomoyuki Tanaka; Katsurou Natori; Naokazu Takeda; Shuji Nakata; Xi Jiang; Mary K Estes
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

9.  Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006.

Authors:  J Joukje Siebenga; Harry Vennema; Bernadet Renckens; Erwin de Bruin; Bas van der Veer; Roland J Siezen; Marion Koopmans
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

Review 10.  Systematic literature review of role of noroviruses in sporadic gastroenteritis.

Authors:  Manish M Patel; Marc-Alain Widdowson; Roger I Glass; Kenichiro Akazawa; Jan Vinjé; Umesh D Parashar
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883
View more
  25 in total

1.  Structural Evolution of the Emerging 2014-2015 GII.17 Noroviruses.

Authors:  Bishal Kumar Singh; Anna Koromyslova; Lisa Hefele; Clara Gürth; Grant S Hansman
Journal:  J Virol       Date:  2015-12-23       Impact factor: 5.103

Review 2.  Burden of norovirus in healthcare facilities and strategies for outbreak control.

Authors:  A Kambhampati; M Koopmans; B A Lopman
Journal:  J Hosp Infect       Date:  2015-02-04       Impact factor: 3.926

3.  Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition.

Authors:  Maria Malm; Kirsi Tamminen; Suvi Lappalainen; Hanni Uusi-Kerttula; Timo Vesikari; Vesna Blazevic
Journal:  Clin Vaccine Immunol       Date:  2015-04-22

Review 4.  Norovirus.

Authors:  Elizabeth Robilotti; Stan Deresinski; Benjamin A Pinsky
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

Review 5.  Advances in norovirus biology.

Authors:  Stephanie M Karst; Christiane E Wobus; Ian G Goodfellow; Kim Y Green; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2014-06-11       Impact factor: 21.023

6.  Potent inhibition of norovirus by dipeptidyl α-hydroxyphosphonate transition state mimics.

Authors:  Sivakoteswara Rao Mandadapu; Mallikarjuna Reddy Gunnam; Anushka C Galasiti Kankanamalage; Roxanne Adeline Z Uy; Kevin R Alliston; Gerald H Lushington; Yunjeong Kim; Kyeong-Ok Chang; William C Groutas
Journal:  Bioorg Med Chem Lett       Date:  2013-08-22       Impact factor: 2.823

7.  Characterization of Antigenic Relatedness between GII.4 and GII.17 Noroviruses by Use of Serum Samples from Norovirus-Infected Patients.

Authors:  Ying-Chun Dai; Ming Xia; Qiong Huang; Ming Tan; Lin Qin; Ya-Li Zhuang; Yan Long; Jian-Dong Li; Xi Jiang; Xu-Fu Zhang
Journal:  J Clin Microbiol       Date:  2017-09-13       Impact factor: 5.948

Review 8.  Norovirus immunology: Of mice and mechanisms.

Authors:  Kira L Newman; Juan S Leon
Journal:  Eur J Immunol       Date:  2015-08-25       Impact factor: 5.532

Review 9.  Epidemiology of human noroviruses and updates on vaccine development.

Authors:  Sasirekha Ramani; Robert L Atmar; Mary K Estes
Journal:  Curr Opin Gastroenterol       Date:  2014-01       Impact factor: 3.287

Review 10.  Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations.

Authors:  Negar Aliabadi; Ben A Lopman; Umesh D Parashar; Aron J Hall
Journal:  Expert Rev Vaccines       Date:  2015-07-29       Impact factor: 5.217
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.